相似文献
1
A rigid bicyclic platform for the generation of conformationally locked neuraminidase inhibitors.
Org Lett. 2012 Dec 7;14(23):5876-9. doi: 10.1021/ol3027939. Epub 2012 Nov 26.
2
A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
J Virol. 2015 Mar;89(5):2820-30. doi: 10.1128/JVI.03246-14. Epub 2014 Dec 24.
3
[Establishment of a cell-based 2009 H1N1 influenza neuraminidase inhibitors evaluation system].
Yao Xue Xue Bao. 2010 Mar;45(3):383-7.
4
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.
5
Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.
6
Molecular and genetic characteristics of hemagglutinin and neuraminidase in Iranian 2009 pandemic influenza A(H1N1) viruses.
Arch Virol. 2010 May;155(5):717-21. doi: 10.1007/s00705-010-0629-9. Epub 2010 Mar 21.
7
Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA.
Influenza Other Respir Viruses. 2012 Mar;6(2):101-9. doi: 10.1111/j.1750-2659.2011.00273.x. Epub 2011 Jul 19.
8
Molecular characterization of the hemagglutinin and neuraminidase genes of H5N1 influenza A viruses isolated from poultry in Vietnam from 2004 to 2005.
J Vet Med Sci. 2006 May;68(5):527-31. doi: 10.1292/jvms.68.527.
9
Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.
10
Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.
PLoS One. 2018 Feb 28;13(2):e0193623. doi: 10.1371/journal.pone.0193623. eCollection 2018.
引用本文的文献
1
Dynamic Properties of Di(cyclopentadienecarboxylic Acid) Dimethyl Esters.
Int J Mol Sci. 2023 Oct 7;24(19):14980. doi: 10.3390/ijms241914980.
2
Efficient synthesis of 3-sulfolenes from allylic alcohols and 1,3-dienes enabled by sodium metabisulfite as a sulfur dioxide equivalent.
Org Biomol Chem. 2018 May 15;16(19):3605-3609. doi: 10.1039/c8ob00745d.
3
Dipolar addition to cyclic vinyl sulfones leading to dual conformation tricycles.
Beilstein J Org Chem. 2013 Jul 15;9:1419-25. doi: 10.3762/bjoc.9.159. eCollection 2013.
本文引用的文献
1
Airborne transmission of influenza A/H5N1 virus between ferrets.
Science. 2012 Jun 22;336(6088):1534-41. doi: 10.1126/science.1213362.
2
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.
Nature. 2012 May 2;486(7403):420-8. doi: 10.1038/nature10831.
3
The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
Bioorg Med Chem Lett. 2011 Dec 1;21(23):7137-41. doi: 10.1016/j.bmcl.2011.09.076. Epub 2011 Sep 24.
4
A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity.
J Am Chem Soc. 2011 Nov 9;133(44):17959-65. doi: 10.1021/ja207892q. Epub 2011 Oct 14.
5
Three Streptococcus pneumoniae sialidases: three different products.
J Am Chem Soc. 2011 Feb 16;133(6):1718-21. doi: 10.1021/ja110733q. Epub 2011 Jan 18.
6
Tandem vinylogous 1,2-addition/anionic oxy-Cope reaction leading from butadiene sulfone to an orthogonally functionalized bicycle.
J Org Chem. 2010 Sep 17;75(18):6312-5. doi: 10.1021/jo101389c.
7
Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1240-9. doi: 10.1345/aph.1P031. Epub 2010 Jun 1.
8
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.
Science. 2009 Oct 30;326(5953):734-6. doi: 10.1126/science.1178258.
9
The evolution of influenza resistance and treatment.
JAMA. 2009 Mar 11;301(10):1066-9. doi: 10.1001/jama.2009.324. Epub 2009 Mar 2.
10
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.
JAMA. 2009 Mar 11;301(10):1034-41. doi: 10.1001/jama.2009.294. Epub 2009 Mar 2.
Zotero 插件
